Active content determination of non-coated pharmaceutical pellets by near infrared spectroscopy: Method development, validation and reliability evaluation

Talanta

Volumn 80, Issue 5, 2010, Pages 1750-1757

  Mantanus, J ^a   Ziemons E ^a   Lebrun, P ^a   Rozet, E ^a   Klinkenberg, R ^b   Streel, B ^b   Evrard, B ^a   Hubert, Ph ^a  

^a UNIVERSITY OF LIÈGE   (Belgium)

^b Galephar Research Center M F   (Belgium)

Author keywords

Accuracy profile; Active content; Multivariate analysis; Near infrared spectroscopy; Pharmaceutical pellets; Process Analytical Technology; Validation

Indexed keywords

CALIBRATION; ERRORS; FORECASTING; LEAST SQUARES APPROXIMATIONS; MEAN SQUARE ERROR; MULTIVARIANT ANALYSIS; NEAR INFRARED SPECTROSCOPY; PELLETIZING; RELIABILITY;

ACCURACY PROFILES; ACTIVE CONTENT; MULTI VARIATE ANALYSIS; PROCESS ANALYTICAL TECHNOLOGY; VALIDATION;

INFRARED DEVICES;

EID: 75749098040     PISSN: 00399140     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.talanta.2009.10.019     Document Type: Article

References (34)

1. Luypaert J., Massart D.L., and Vander Heyden Y. Talanta 72 (2007) 865
2. Roggo Y., Chalus P., Maurer L., Lema-Martinez C., Edmond A., and Jent N. J. Pharm. Biomed. Anal. 44 (2007) 683
3. Burns D.A., and Ciurczak E.W. Handbook of Near-Infrared Analysis. 3rd ed. vol. 35 (2008), CRC Press, New York
4. American Food and Drug Administration (FDA). Guidance for Industry PAT-A Framework for Innovative Pharmaceutical Manufacturing and Quality Assurance (2004), FDA
5. International Conference on Harmonisation (ICH) of technical requirements for registration of pharmaceuticals for human use, Topic Q8: Pharmaceutical Development, Geneva, 2005.
6. Lopes J.A., Costa P.F., Alves T.P., and Menezes J.C. Chemo. Intel. Lab. Syst. 74 (2004) 269
7. Moes J.J., Ruijken M.M., Gout E., Frijlink H.W., and Ugwoke M.I. Int. J. Pharm. 357 (2008) 108
8. Bodson C., Dewé W., Hubert Ph., and Delattre L. J. Pharm. Biomed. Anal. 41 (2006) 783
9. Bodson C., Rozet E., Ziémons E., Evrard B., Hubert Ph., and Delattre L. J. Pharm. Biomed. Anal. 45 (2007) 356
10. Mantanus J., et al. Anal. Chim. Acta (2008) 10.1016/j.aca.2008.12.031
11. Rantanen J., Räsänen E., Antikainen O., Mannermaa J.-P., and Yliruusi J. Chemo. Intel. Lab. Syst. 56 (2001) 51
12. N. Sandler, J. Rantanen, J. Heinämäki, M. Römer, M. Marvola, J. Yliruusi, AAPS PharmSciTech. 6 (2) (2005) Article 26.
13. Ito M., Suzuki T., Yada S., Kusai A., Nakagami H., Yonemochi E., and Terada K. J. Pharm. Biomed. Anal. 47 (2008) 819
14. Rodrigues L.O., Cardoso J.P., and Menezes J.C. Talanta 75 (2008) 1203
15. Rosa S.S., Barata P.A., Martins J.M., and Menezes J.C. Talanta 75 (2008) 725
16. Huang H., Yu H., Xu H., and Ying Y. J. Food Eng. 87 (2008) 303
17. Chen Q., Zhao J., Chaitep S., and Guo Z. Food Chem. 113 (2009) 1272
18. Monteiro M.R., Ambrozin A.R.P., Liao L.M., and Ferreira A.G. Talanta 77 (2008) 593
19. International Conference on Harmonization (ICH) of Technical Requirements for registration of Pharmaceuticals for human use, Topic Q2 (R1): Validation of Analytical Procedures: Text and Methodology, Geneva, 2005.
20. Hubert Ph., Nguyen-Huu J.J., Boulanger B., Chapuzet E., Chiap P., Cohen N., Compagnon P.A., Dewé W., Feinberg M., Lallier M., Laurentie M., Mercier N., Muzard G., Nivet C., and Valat L. J. Pharm. Biomed. Anal. 36 (2004) 579
21. Hubert Ph., Nguyen-Huu J.J., Boulanger B., Chapuzet E., Chiap P., Cohen N., Compagnon P.A., Dewé W., Feinberg M., Lallier M., Laurentie M., Mercier N., Muzard G., Nivet C., Valat L., and Rozet E. J. Pharm. Biomed. Anal. 45 (2007) 70
22. Hubert Ph., Nguyen-Huu J.J., Boulanger B., Chapuzet E., Cohen N., Compagnon P.-A., Dewé W., Feinberg M., Laurentie M., Mercier N., Muzard G., Valat L., and Rozet E. J. Pharm. Biomed. Anal. 45 (2007) 82
23. Hubert Ph., Chiap P., Crommen J., Boulanger B., Chapuzet E., Mercier N., Bervoas-Martin S., Chevalier P., Grandjean D., Lagorce P., Lallier M., Laparra M.C., Laurentie M., and Nivet J.C. Anal. Chim. Acta 391 (1999) 135
24. Rozet E., Ceccato A., Hubert C., Ziémons E., Oprean R., Rudaz S., Boulanger B., and Hubert P. J. Chromatogr. A 1158 (2007) 111
25. Rozet E., Morello R., Lecomte F., Martin G.B., Chiap P., Crommen J., Boos K.S., and Hubert P. J. Chromatogr. B 844 (2006) 251
26. Rozet E., Wascotte V., Lecouturier N., Préat V., Dewé W., Boulanger B., and Hubert Ph. Anal. Chim. Acta 591 (2007) 239
27. Rozet E., Hubert C., Ceccato A., Dewé W., Ziemons E., Moonen F., Michail K., Wintersteiger R., Streel B., Boulanger B., and Hubert Ph. J. Chromatogr. A 1158 (2007) 126
28. Feinberg M., Boulanger B., Dewé W., and Hubert Ph. Anal. Bioanal. Chem. 380 (2004) 502
29. International Conference on Harmonisation (ICH) of technical requirements for registration of pharmaceuticals for human use, Topic Q9: Quality Risk Management, Geneva, 2005.
30. European Medicines Agency, draft: guideline on the use of near infrared spectroscopy by the pharmaceutical industry and the data requirements for new submissions and variations, EMEA/CHMP/CVMP/QWP/17760/2009 Rev 1.
31. Analytical Methods Committee. Analyst 120 (1995) 2303
32. Eurachem/Citac guide quantifying the uncertainty in analytical measurement, second ed., 2000.
33. CB EA-4/16, EA Guidelines on the Expression of Uncertainty in Quantitative Testing, 2004, http://www.european-accreditation.org.
34. Marini R.D., Chiap P., Boulanger B., Rudaz S., Rozet E., Crommen J., and Hubert Ph. Talanta 68 (2006) 1166